Published in Blood Weekly, April 3rd, 2008
"The first (n = 17) and second (n = 24) groups were treated with E (E+: 10 mg/d) and L (L+: 50 mg/d) alone, respectively. The third positive control group (n...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.